Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cytyc buys Adiana for $60mm cash, plus earn-out

Executive Summary

Cytyc (women's health and cancer diagnostics) has agreed to acquire Adiana, a private company that has created a non-incisional alternative to a permanent form of contraception-tubal ligation. Cytyc will pay $60mm in cash up front, plus a milestone payment for FDA approval and an earn-out based on four years of sales; altogether the transaction will not exceed $215mm.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register